Filing Flows › Pulse Biosciences (PLSE) › Who owns the stock
Who owns Pulse Biosciences (PLSE) stock
107 funds reported Pulse Biosciences (PLSE) shares in their latest 13F filings, worth $311M in all. The largest holder is BlackRock ($40.7M). Last quarter 57 funds added to their stakes and 27 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 1,466,702 | $40.7M | increase | 2026-06-30 |
| Bank of America | 1,446,611 | $40.1M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 788,640 | $21.9M | decrease | 2026-06-30 |
| Portolan Capital Management, LLC | 753,333 | $20.9M | increase | 2026-06-30 |
| Price T Rowe Associates | 748,638 | $20.8M | increase | 2026-06-30 |
| Balyasny Asset Management L.P. | 718,103 | $19.9M | increase | 2026-06-30 |
| Citadel Advisors LLC | 626,514 | $17.4M | increase | 2026-06-30 |
| Vanguard Group | 1,118,743 | $15.4M | increase | 2025-12-31 |
| Geode Capital Management, LLC | 536,276 | $14.9M | increase | 2026-06-30 |
| State Street | 529,624 | $14.7M | increase | 2026-06-30 |
| Massachusetts Financial Services | 462,734 | $12.8M | decrease | 2026-06-30 |
| UBS Group AG | 275,669 | $7.6M | increase | 2026-06-30 |
| Griffin Asset Management | 144,211 | $7.2M | decrease | 2026-09-30 |
| Vanguard Portfolio Management LLC | 179,497 | $5.0M | increase | 2026-06-30 |
| Northern Trust | 173,590 | $4.8M | decrease | 2026-06-30 |
Pulse Biosciences' latest quarter
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most PLSE stock?
By the latest 13F filings: BlackRock ($40.7M); Bank of America ($40.1M); Vanguard Capital Management LLC ($21.9M); Portolan Capital Management, LLC ($20.9M); Price T Rowe Associates ($20.8M).
What is the short interest in PLSE?
3,004,624 shares were sold short at the 2026-10-15 settlement, -9.29% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.